JPWO2020172686A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020172686A5
JPWO2020172686A5 JP2021549163A JP2021549163A JPWO2020172686A5 JP WO2020172686 A5 JPWO2020172686 A5 JP WO2020172686A5 JP 2021549163 A JP2021549163 A JP 2021549163A JP 2021549163 A JP2021549163 A JP 2021549163A JP WO2020172686 A5 JPWO2020172686 A5 JP WO2020172686A5
Authority
JP
Japan
Prior art keywords
seq
nos
iapp peptide
iapp
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021549163A
Other languages
English (en)
Japanese (ja)
Other versions
JP7505713B2 (ja
JP2022521266A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/019557 external-priority patent/WO2020172686A1/en
Publication of JP2022521266A publication Critical patent/JP2022521266A/ja
Publication of JPWO2020172686A5 publication Critical patent/JPWO2020172686A5/ja
Application granted granted Critical
Publication of JP7505713B2 publication Critical patent/JP7505713B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021549163A 2019-02-22 2020-02-24 アミロイドペプチドバリアント Active JP7505713B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962809167P 2019-02-22 2019-02-22
US62/809,167 2019-02-22
PCT/US2020/019557 WO2020172686A1 (en) 2019-02-22 2020-02-24 Amyloid peptide variants

Publications (3)

Publication Number Publication Date
JP2022521266A JP2022521266A (ja) 2022-04-06
JPWO2020172686A5 true JPWO2020172686A5 (zh) 2022-11-14
JP7505713B2 JP7505713B2 (ja) 2024-06-25

Family

ID=

Similar Documents

Publication Publication Date Title
JP5042312B2 (ja) Hghを含む経口送達用医薬組成物
RU2466738C2 (ru) Фрагменты vip и способы их применения
JP2022191257A5 (zh)
JP2008501723A (ja) 循環器病の治療のための組成物および方法
JP2009544585A5 (zh)
EP3846821B1 (en) Combination therapy for the treatment of liver disease
JP2021502392A5 (zh)
US10076511B2 (en) Bisamide derivative of dicarboxylic acid as an agent for stimulating tissue regeneration and recovery of diminished tissue function
JP2002511875A (ja) 勃起機能障害治療用のヨヒンビンおよびアルギニン含有薬
WO2022042541A1 (zh) 眼镜蛇蛇毒或其提取物在制备降尿酸和/或抗痛风性关节炎的药物中的应用
JP2002530353A5 (zh)
US11628163B2 (en) 1-piperidinepropionic acid for treating a fibrosing disease
JPWO2020172686A5 (zh)
US3681497A (en) Therapeutic methods of employing hydrogen maleate salt of n-(d-6-methyl-8-isoergolenyl)-n{40 ,n{40 -diethyl-carbamide
WO2019171333A1 (en) Treatment of demyelinating diseases
TAUBENHAUS et al. Clinical and histological observations on a case of scleroderma treated with cortisone
JP2022035920A5 (zh)
JP2004529158A5 (zh)
JP5667238B2 (ja) 治療のためのヒストンの使用方法
JP2001089370A (ja) 肝疾患治療剤
Naqoosh et al. A rare case of Mandibular Mucormycosis in a Post-COVID-19 patient
WO2021024855A1 (ja) 線維筋痛症の治療薬又は予防薬
WO1999039703A1 (fr) Medicaments preventifs et curatifs de troubles de la muqueuse intestinale
JPWO2021021915A5 (zh)
JPWO2019152627A5 (zh)